(+)-taxifolin increases expression ISO RGD:1344001 6480464 taxifolin results in increased expression of GDF15 mRNA CTD PMID:17541156 (-)-demecolcine increases expression ISO RGD:1344001 6480464 Demecolcine results in increased expression of GDF15 mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions ISO RGD:735622 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GDF15 mRNA CTD PMID:36331819 (S)-colchicine decreases expression ISO RGD:1344001 6480464 Colchicine results in decreased expression of GDF15 mRNA CTD PMID:24211769 1,1-dichloroethene increases expression ISO RGD:735622 6480464 vinylidene chloride results in increased expression of GDF15 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of GDF15 mRNA CTD PMID:27840820 , PMID:32387197 1,2-dimethylhydrazine increases expression ISO RGD:735622 6480464 1, 2-Dimethylhydrazine results in increased expression of GDF15 mRNA CTD PMID:22206623 1-(5-isoquinolinesulfonyl)-2-methylpiperazine multiple interactions ISO RGD:1344001 6480464 [SB 203580 co-treated with 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine] inhibits the reaction [jasplakinolide results in increased expression of GDF15 protein] more ... CTD PMID:23996089 17beta-estradiol increases expression ISO RGD:735622 6480464 Estradiol results in increased expression of GDF15 mRNA CTD PMID:25210133 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of GDF15 mRNA CTD PMID:31119341 17beta-estradiol increases expression ISO RGD:1344001 6480464 Estradiol results in increased expression of GDF15 mRNA CTD PMID:19619570 more ... 17beta-estradiol decreases expression ISO RGD:1344001 6480464 Estradiol results in decreased expression of GDF15 mRNA CTD PMID:19167446 17beta-estradiol multiple interactions ISO RGD:1344001 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of GDF15 mRNA more ... CTD PMID:19619570 more ... 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:1344001 6480464 Metribolone results in increased expression of GDF15 mRNA CTD PMID:17010196 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1344001 6480464 Dihydrotestosterone results in increased expression of GDF15 mRNA CTD PMID:16523695 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1344001 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1344001 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of GDF15 mRNA more ... CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1344001 6480464 Tetrachlorodibenzodioxin results in decreased expression of GDF15 mRNA CTD PMID:36370075 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1344001 6480464 Tetrachlorodibenzodioxin results in increased expression of GDF15 mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735622 6480464 Tetrachlorodibenzodioxin affects the expression of GDF15 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GDF15 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GDF15 mRNA CTD PMID:21215274 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1344001 6480464 Tetrachlorodibenzodioxin affects the expression of GDF15 mRNA CTD PMID:22298810 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1344001 6480464 2 more ... CTD PMID:26705709 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of GDF15 mRNA CTD PMID:21346803 2,6-dichloroindophenol multiple interactions ISO RGD:1344001 6480464 [2, 6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of GDF15 mRNA CTD PMID:21034357 2-acetamidofluorene increases expression ISO RGD:735622 6480464 2-Acetylaminofluorene results in increased expression of GDF15 mRNA CTD PMID:21607683 2-butoxyethanol increases expression ISO RGD:735622 6480464 n-butoxyethanol results in increased expression of GDF15 mRNA CTD PMID:19812364 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of GDF15 mRNA CTD PMID:14600272 more ... 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1344001 6480464 3 more ... CTD PMID:19692669 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:32119087 3,3',4,4'-tetrachlorobiphenyl affects expression ISO RGD:1344001 6480464 3 more ... CTD PMID:20638727 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1344001 6480464 tetrabromobisphenol A results in increased expression of GDF15 protein CTD PMID:31675489 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO RGD:1344001 6480464 [PPARG protein results in increased susceptibility to tetrabromobisphenol A] which results in increased expression of GDF15 mRNA CTD PMID:35734227 3,3'-diindolylmethane increases expression ISO RGD:1344001 6480464 3, 3'-diindolylmethane results in increased expression of GDF15 mRNA CTD PMID:15670751 3,4-dichloroaniline increases expression EXP 6480464 3, 4-dichloroaniline results in increased expression of GDF15 mRNA CTD PMID:24172598 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1344001 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GDF15 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of GDF15 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1344001 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GDF15 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol affects methylation ISO RGD:735622 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of GDF15 gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases expression ISO RGD:735622 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of GDF15 mRNA CTD PMID:33297965 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GDF15 mRNA CTD PMID:14600272 more ... 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression ISO RGD:1344001 6480464 Am 580 results in increased expression of GDF15 mRNA CTD PMID:16982809 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of GDF15 mRNA CTD PMID:21346803 4-Hydroxybenzophenone increases expression ISO RGD:735622 6480464 4-hydroxybenzophenone results in increased expression of GDF15 mRNA CTD PMID:35476924 4-hydroxyphenyl retinamide increases expression ISO RGD:1344001 6480464 Fenretinide results in increased expression of GDF15 mRNA, Fenretinide results in increased expression of GDF15 protein CTD PMID:15958647 , PMID:16671099 4-hydroxyphenyl retinamide increases expression ISO RGD:735622 6480464 Fenretinide results in increased expression of GDF15 mRNA CTD PMID:28973697 5-(2-methylpiperazine-1-sulfonyl)isoquinoline multiple interactions ISO RGD:1344001 6480464 [SB 203580 co-treated with 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine] inhibits the reaction [jasplakinolide results in increased expression of GDF15 protein] more ... CTD PMID:23996089 5-aza-2'-deoxycytidine affects expression ISO RGD:1344001 6480464 Decitabine affects the expression of GDF15 mRNA CTD PMID:17145863 , PMID:23300844 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1344001 6480464 Decitabine promotes the reaction [[trichostatin A affects the methylation of GDF15 promoter] which affects the expression of GDF15 mRNA], Decitabine promotes the reaction [[trichostatin A affects the methylation of GDF15 promoter] which affects the expression of GDF15 protein] CTD PMID:18801729 5-aza-2'-deoxycytidine increases expression ISO RGD:735622 6480464 Decitabine results in increased expression of GDF15 mRNA CTD PMID:27915011 5-bromo-2'-deoxyuridine multiple interactions ISO RGD:735622 6480464 [Bromodeoxyuridine co-treated with furan] results in increased expression of GDF15 mRNA CTD PMID:24910943 5-fluorouracil increases expression ISO RGD:1344001 6480464 Fluorouracil results in increased expression of GDF15 mRNA, Fluorouracil results in increased expression of GDF15 protein CTD PMID:14665630 more ... 5-fluorouracil multiple interactions ISO RGD:1344001 6480464 TP53 protein affects the reaction [Fluorouracil results in increased expression of GDF15 mRNA] CTD PMID:15016801 7,12-dimethyltetraphene increases expression ISO RGD:735622 6480464 9 more ... CTD PMID:32553695 8-Br-cAMP increases expression ISO RGD:1344001 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GDF15 mRNA CTD PMID:22079614 9-cis-retinoic acid increases expression ISO RGD:1344001 6480464 Alitretinoin results in increased expression of GDF15 mRNA CTD PMID:15982314 [6]-Shogaol increases expression ISO RGD:1344001 6480464 shogaol results in increased expression of GDF15 mRNA CTD PMID:25148906 aceclofenac increases expression ISO RGD:1344001 6480464 aceclofenac results in increased expression of GDF15 protein CTD PMID:15555568 aceclofenac increases expression ISO RGD:735622 6480464 aceclofenac results in increased expression of GDF15 mRNA CTD PMID:18076062 acetamide increases expression EXP 6480464 acetamide results in increased expression of GDF15 mRNA CTD PMID:31881176 acetylsalicylic acid increases expression ISO RGD:1344001 6480464 Aspirin results in increased expression of GDF15 mRNA, Aspirin results in increased expression of GDF15 protein CTD PMID:14976132 , PMID:15180942 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of GDF15 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:1344001 6480464 Acrylamide results in increased expression of GDF15 mRNA CTD PMID:32763439 , PMID:35690182 acrylamide increases expression ISO RGD:735622 6480464 Acrylamide results in increased expression of GDF15 mRNA CTD PMID:30807115 actinomycin D multiple interactions ISO RGD:1344001 6480464 Dactinomycin inhibits the reaction [resveratrol results in increased expression of GDF15 mRNA] CTD PMID:17257620 adefovir pivoxil increases expression ISO RGD:1344001 6480464 adefovir dipivoxil results in increased expression of GDF15 mRNA CTD PMID:25596134 adenine decreases expression ISO RGD:1344001 6480464 Adenine results in decreased expression of GDF15 mRNA CTD PMID:24211769 aflatoxin B1 affects expression ISO RGD:1344001 6480464 Aflatoxin B1 affects the expression of GDF15 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1344001 6480464 Aflatoxin B1 results in increased expression of GDF15 mRNA CTD PMID:21632981 more ... aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GDF15 mRNA CTD PMID:14600272 more ... all-trans-4-oxoretinoic acid increases expression ISO RGD:1344001 6480464 4-oxoretinoic acid results in increased expression of GDF15 mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression ISO RGD:1344001 6480464 Tretinoin results in decreased expression of GDF15 mRNA CTD PMID:17045167 all-trans-retinoic acid increases expression ISO RGD:1344001 6480464 Tretinoin metabolite results in increased expression of GDF15 mRNA, Tretinoin results in increased expression of GDF15 mRNA CTD PMID:15982314 , PMID:23830798 amiodarone increases expression ISO RGD:1344001 6480464 Amiodarone results in increased expression of GDF15 mRNA CTD PMID:19774075 , PMID:36586010 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GDF15 mRNA CTD PMID:16483693 amphibole asbestos affects expression ISO RGD:1344001 6480464 Asbestos, Amphibole affects the expression of GDF15 protein CTD PMID:20855422 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1344001 6480464 pyrazolanthrone promotes the reaction [silybin results in increased expression of GDF15 protein] CTD PMID:24440808 antimycin A increases expression ISO RGD:1344001 6480464 Antimycin A results in increased expression of GDF15 mRNA CTD PMID:33512557 arecoline increases expression ISO RGD:1344001 6480464 Arecoline results in increased expression of GDF15 mRNA CTD PMID:17682004 aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of GDF15 mRNA CTD PMID:23912714 aristolochic acid A increases expression ISO RGD:1344001 6480464 aristolochic acid I results in increased expression of GDF15 mRNA CTD PMID:33212167 arsane decreases expression ISO RGD:1344001 6480464 Arsenic results in decreased expression of GDF15 mRNA CTD PMID:12773770 arsenic atom decreases expression ISO RGD:1344001 6480464 Arsenic results in decreased expression of GDF15 mRNA CTD PMID:12773770 arsenite(3-) multiple interactions ISO RGD:1344001 6480464 arsenite promotes the reaction [G3BP1 protein binds to GDF15 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:1344001 6480464 Arsenic Trioxide results in increased expression of GDF15 mRNA CTD PMID:19036111 more ... atrazine increases expression ISO RGD:1344001 6480464 Atrazine results in increased expression of GDF15 mRNA CTD PMID:22378314 Aurin increases expression ISO RGD:1344001 6480464 aurin results in increased expression of GDF15 mRNA CTD PMID:25477506 azathioprine increases expression ISO RGD:1344001 6480464 Azathioprine results in increased expression of GDF15 mRNA CTD PMID:22623647 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GDF15 mRNA CTD PMID:33854195 azoxystrobin increases expression ISO RGD:1344001 6480464 azoxystrobin results in increased expression of GDF15 mRNA CTD PMID:33512557 benzo[a]pyrene increases expression ISO RGD:735622 6480464 Benzo(a)pyrene metabolite results in increased expression of GDF15 mRNA, Benzo(a)pyrene results in increased expression of GDF15 mRNA CTD PMID:21569818 more ... benzo[a]pyrene multiple interactions ISO RGD:735622 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GDF15 mRNA, [Benzo(a)pyrene results in increased activity of AHR protein] which results in increased expression of GDF15 mRNA CTD PMID:27858113 , PMID:32553695 benzo[a]pyrene increases expression ISO RGD:1344001 6480464 Benzo(a)pyrene results in increased expression of GDF15 mRNA CTD PMID:20064835 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:1344001 6480464 7 more ... CTD PMID:19150397 more ... benzo[b]fluoranthene increases expression ISO RGD:735622 6480464 benzo(b)fluoranthene results in increased expression of GDF15 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:735622 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GDF15 mRNA CTD PMID:27858113 Benzo[ghi]perylene increases expression ISO RGD:735622 6480464 1, 12-benzoperylene results in increased expression of GDF15 mRNA CTD PMID:26377693 Benzo[k]fluoranthene decreases expression ISO RGD:735622 6480464 benzo(k)fluoranthene results in decreased expression of GDF15 mRNA CTD PMID:26377693 beta-naphthoflavone increases expression ISO RGD:1344001 6480464 beta-Naphthoflavone results in increased expression of GDF15 mRNA CTD PMID:19737606 beta-naphthoflavone decreases expression ISO RGD:1344001 6480464 beta-Naphthoflavone results in decreased expression of GDF15 mRNA CTD PMID:32858204 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of GDF15 mRNA CTD PMID:15651846 bis(2-chloroethyl) sulfide increases expression ISO RGD:1344001 6480464 Mustard Gas results in increased expression of GDF15 mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate increases expression ISO RGD:735622 6480464 Diethylhexyl Phthalate results in increased expression of GDF15 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1344001 6480464 Diethylhexyl Phthalate results in increased expression of GDF15 mRNA CTD PMID:31163220 bisphenol A affects expression ISO RGD:1344001 6480464 bisphenol A affects the expression of GDF15 mRNA CTD PMID:20170705 , PMID:30903817 bisphenol A increases expression ISO RGD:735622 6480464 bisphenol A results in increased expression of GDF15 mRNA CTD PMID:32156529 , PMID:33221593 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GDF15 mRNA CTD PMID:30903817 bisphenol A increases secretion ISO RGD:1344001 6480464 bisphenol A results in increased secretion of GDF15 protein CTD PMID:27745655 bisphenol A increases expression ISO RGD:1344001 6480464 bisphenol A results in increased expression of GDF15 mRNA CTD PMID:25047013 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GDF15 mRNA CTD PMID:25181051 , PMID:35192832 bortezomib multiple interactions ISO RGD:1344001 6480464 [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased expression of GDF15 mRNA CTD PMID:25522274 bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of GDF15 mRNA CTD PMID:20830808 bromoacetate increases expression ISO RGD:1344001 6480464 bromoacetate results in increased expression of GDF15 mRNA CTD PMID:19753638 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of GDF15 mRNA CTD PMID:32479839 buta-1,3-diene increases expression ISO RGD:735622 6480464 1, 3-butadiene results in increased expression of GDF15 mRNA CTD PMID:29038090 butan-1-ol multiple interactions ISO RGD:1344001 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GDF15 mRNA CTD PMID:29432896 butanal increases expression ISO RGD:1344001 6480464 butyraldehyde results in increased expression of GDF15 mRNA CTD PMID:26079696 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of GDF15 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:1344001 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GDF15 mRNA CTD PMID:31738976 cadmium dichloride multiple interactions ISO RGD:1344001 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GDF15 mRNA, [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GDF15 mRNA CTD PMID:12634122 , PMID:31738976 cadmium dichloride increases expression ISO RGD:735622 6480464 Cadmium Chloride results in increased expression of GDF15 mRNA CTD PMID:29408670 cadmium dichloride increases expression ISO RGD:1344001 6480464 Cadmium Chloride results in increased expression of GDF15 mRNA CTD PMID:25596134 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GDF15 mRNA CTD PMID:19010381 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of GDF15 mRNA CTD PMID:22110744 calcitriol increases expression ISO RGD:1344001 6480464 Calcitriol results in increased expression of GDF15 mRNA, Calcitriol results in increased expression of GDF15 protein CTD PMID:15386353 , PMID:16523695 cannabidiol increases expression ISO RGD:735622 6480464 Cannabidiol results in increased expression of GDF15 mRNA CTD PMID:21542829 cannabidiol multiple interactions ISO RGD:1344001 6480464 [Dronabinol co-treated with Cannabidiol] results in increased expression of GDF15 mRNA CTD PMID:26504004 cannabidiol increases expression ISO RGD:1344001 6480464 Cannabidiol results in increased expression of GDF15 mRNA CTD PMID:26504004 , PMID:33244087 capsaicin multiple interactions ISO RGD:1344001 6480464 [CEBPB protein binds to GDF15 promoter] promotes the reaction [Capsaicin results in increased expression of GDF15 mRNA] more ... CTD PMID:20110283 capsaicin increases phosphorylation ISO RGD:1344001 6480464 Capsaicin results in increased phosphorylation of GDF15 protein CTD PMID:20110283 capsaicin increases expression ISO RGD:1344001 6480464 Capsaicin results in increased expression of GDF15 mRNA CTD PMID:20110283 carbamazepine affects expression ISO RGD:1344001 6480464 Carbamazepine affects the expression of GDF15 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1344001 6480464 Nanotubes, Carbon results in increased expression of GDF15 mRNA CTD PMID:24389112 carbon nanotube increases expression ISO RGD:735622 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:735622 6480464 Nanotubes more ... CTD PMID:25620056 carbonyl cyanide p-trifluoromethoxyphenylhydrazone increases expression ISO RGD:1344001 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in increased expression of GDF15 mRNA CTD PMID:16039398 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of GDF15 mRNA CTD PMID:18500788 celastrol increases expression ISO RGD:1344001 6480464 celastrol results in increased expression of GDF15 mRNA CTD PMID:17010675 celecoxib multiple interactions ISO RGD:1344001 6480464 [Celecoxib co-treated with Octreotide] results in increased expression of GDF15 mRNA more ... CTD PMID:17257745 more ... celecoxib increases expression ISO RGD:1344001 6480464 Celecoxib results in increased expression of GDF15, Celecoxib results in increased expression of GDF15 mRNA CTD PMID:17257745 more ... chlordecone decreases expression ISO RGD:735622 6480464 Chlordecone results in decreased expression of GDF15 mRNA CTD PMID:33711761 chloroacetaldehyde increases expression ISO RGD:1344001 6480464 chloroacetaldehyde results in increased expression of GDF15 mRNA CTD PMID:25596134 chloropicrin increases expression ISO RGD:1344001 6480464 chloropicrin results in increased expression of GDF15 mRNA CTD PMID:26352163 chloroprene increases expression ISO RGD:735622 6480464 Chloroprene results in increased expression of GDF15 mRNA CTD PMID:23125180 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of GDF15 mRNA CTD PMID:25596134 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GDF15 mRNA CTD PMID:33854195 chromium(6+) affects expression ISO RGD:735622 6480464 chromium hexavalent ion affects the expression of GDF15 mRNA CTD PMID:28472532 chrysene decreases expression ISO RGD:735622 6480464 chrysene results in decreased expression of GDF15 mRNA CTD PMID:26377693 chrysene multiple interactions ISO RGD:735622 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GDF15 mRNA CTD PMID:27858113 cidofovir anhydrous increases expression ISO RGD:1344001 6480464 Cidofovir results in increased expression of GDF15 mRNA CTD PMID:25596134 ciguatoxin CTX1B affects expression ISO RGD:735622 6480464 Ciguatoxins affects the expression of GDF15 mRNA CTD PMID:18353800 cisplatin multiple interactions ISO RGD:1344001 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of GDF15 mRNA], Folic Acid affects the reaction [Cisplatin affects the expression of GDF15 mRNA] CTD PMID:16898872 , PMID:21858171 cisplatin increases expression ISO RGD:1344001 6480464 Cisplatin results in increased expression of GDF15 mRNA CTD PMID:21532991 more ... cisplatin affects expression ISO RGD:1344001 6480464 Cisplatin affects the expression of GDF15 mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:735622 6480464 Cisplatin results in increased expression of GDF15 mRNA CTD PMID:21151649 clodronic acid decreases expression ISO RGD:1344001 6480464 Clodronic Acid results in decreased expression of GDF15 mRNA CTD PMID:25596134 clofibrate multiple interactions ISO RGD:735622 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GDF15 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GDF15 mRNA] CTD PMID:17585979 clothianidin increases expression ISO RGD:1344001 6480464 clothianidin results in increased expression of GDF15 mRNA CTD PMID:35690182 clozapine increases expression ISO RGD:1344001 6480464 Clozapine results in increased expression of GDF15 protein CTD PMID:36482696 cobalt atom multiple interactions ISO RGD:1344001 6480464 [tungsten carbide binds to Cobalt] which affects the expression of GDF15 mRNA CTD PMID:20105288 cobalt dichloride decreases expression ISO RGD:1344001 6480464 cobaltous chloride results in decreased expression of GDF15 mRNA CTD PMID:20105288 cobalt dichloride increases expression ISO RGD:1344001 6480464 cobaltous chloride results in increased expression of GDF15 mRNA CTD PMID:19376846 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of GDF15 mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:735622 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of GDF15 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:735622 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of GDF15 mRNA CTD PMID:15467011 copper(II) sulfate increases expression ISO RGD:1344001 6480464 Copper Sulfate results in increased expression of GDF15 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1344001 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDF15 mRNA CTD PMID:19167446 coumestrol decreases expression ISO RGD:1344001 6480464 Coumestrol results in decreased expression of GDF15 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1344001 6480464 Asbestos, Crocidolite results in increased expression of GDF15 mRNA CTD PMID:18687144 crocidolite asbestos affects expression ISO RGD:1344001 6480464 Asbestos, Crocidolite affects the expression of GDF15 mRNA CTD PMID:25757056 cryptolepine increases expression ISO RGD:1344001 6480464 cryptolepine results in increased expression of GDF15 mRNA CTD PMID:16120219 CU-O LINKAGE increases expression ISO RGD:1344001 6480464 cupric oxide results in increased expression of GDF15 mRNA CTD PMID:22077320 cycloheximide multiple interactions ISO RGD:1344001 6480464 Cycloheximide inhibits the reaction [trichostatin A affects the expression of GDF15 mRNA] more ... CTD PMID:14662774 , PMID:18801729 cyclosporin A increases expression ISO RGD:1344001 6480464 Cyclosporine results in increased expression of GDF15 mRNA CTD PMID:19159671 more ... cylindrospermopsin increases expression ISO RGD:1344001 6480464 cylindrospermopsin results in increased expression of GDF15 mRNA CTD PMID:23726867 , PMID:24921660 daunorubicin increases expression ISO RGD:1344001 6480464 Daunorubicin results in increased expression of GDF15 mRNA CTD PMID:26537877 , PMID:28940058 decabromodiphenyl ether increases expression ISO RGD:1344001 6480464 decabromobiphenyl ether results in increased expression of GDF15 protein CTD PMID:31675489 deguelin increases expression ISO RGD:1344001 6480464 deguelin results in increased expression of GDF15 mRNA CTD PMID:33512557 dexamethasone decreases expression ISO RGD:735622 6480464 Dexamethasone results in decreased expression of GDF15 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1344001 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GDF15 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of GDF15 mRNA CTD PMID:28628672 dexamethasone decreases expression ISO RGD:1344001 6480464 Dexamethasone results in decreased expression of GDF15 mRNA CTD PMID:25047013 diallyl disulfide increases expression ISO RGD:1344001 6480464 diallyl disulfide results in increased expression of GDF15 protein CTD PMID:11925476 diallyl disulfide multiple interactions ISO RGD:1344001 6480464 TP53 protein affects the reaction [diallyl disulfide results in increased expression of GDF15 protein] CTD PMID:11925476 diarsenic trioxide increases expression ISO RGD:1344001 6480464 Arsenic Trioxide results in increased expression of GDF15 mRNA CTD PMID:19036111 more ... dibenz[a,h]anthracene increases expression ISO RGD:735622 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:735622 6480464 Dibutyl Phthalate results in increased expression of GDF15 mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions ISO RGD:1344001 6480464 [Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GDF15 protein CTD PMID:30218697 dibutyl phthalate decreases expression ISO RGD:735622 6480464 Dibutyl Phthalate results in decreased expression of GDF15 mRNA CTD PMID:17361019 , PMID:21266533 dichloroacetic acid increases expression ISO RGD:735622 6480464 Dichloroacetic Acid results in increased expression of GDF15 mRNA CTD PMID:28962523 dichromium trioxide multiple interactions ISO RGD:1344001 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GDF15 mRNA CTD PMID:12634122 diclofenac increases expression ISO RGD:735622 6480464 Diclofenac results in increased expression of GDF15 mRNA CTD PMID:18076062 diclofenac increases expression ISO RGD:1344001 6480464 Diclofenac results in increased expression of GDF15 protein CTD PMID:15555568 dicrotophos increases expression ISO RGD:1344001 6480464 dicrotophos results in increased expression of GDF15 mRNA CTD PMID:28302478 Didecyldimethylammonium increases expression ISO RGD:1344001 6480464 didecyldimethylammonium results in increased expression of GDF15 mRNA CTD PMID:32763356 diethyl maleate increases expression ISO RGD:1344001 6480464 diethyl maleate results in increased expression of GDF15 mRNA CTD PMID:33545341 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of GDF15 mRNA CTD PMID:15890375 dihydroxyacetone decreases expression ISO RGD:1344001 6480464 Dihydroxyacetone results in decreased expression of GDF15 mRNA CTD PMID:32506039 dimethylarsinic acid multiple interactions ISO RGD:735622 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GDF15 mRNA CTD PMID:34876320 dioxygen multiple interactions ISO RGD:1344001 6480464 Oxygen deficiency inhibits the reaction [darinaparsin results in decreased expression of GDF15 mRNA] CTD PMID:22535156 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GDF15 mRNA CTD PMID:33729688 dioxygen multiple interactions ISO RGD:735622 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GDF15 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:735622 6480464 Oxygen results in increased expression of GDF15 CTD PMID:28734801 dioxygen decreases expression ISO RGD:1344001 6480464 Oxygen deficiency results in decreased expression of GDF15 mRNA CTD PMID:26516004 dioxygen increases expression ISO RGD:1344001 6480464 Oxygen deficiency results in increased expression of GDF15 mRNA more ... CTD PMID:25596134 , PMID:28734801 disodium selenite increases expression ISO RGD:1344001 6480464 Sodium Selenite results in increased expression of GDF15 mRNA CTD PMID:24383545 diuron increases expression EXP 6480464 Diuron metabolite results in increased expression of GDF15 mRNA, Diuron results in increased expression of GDF15 mRNA CTD PMID:24172598 , PMID:25152437 divanadium pentaoxide increases expression ISO RGD:1344001 6480464 vanadium pentoxide results in increased expression of GDF15 mRNA CTD PMID:17459161 dorsomorphin multiple interactions ISO RGD:1344001 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1344001 6480464 Doxorubicin results in decreased expression of GDF15 mRNA CTD PMID:16705698 doxorubicin increases expression ISO RGD:1344001 6480464 Doxorubicin results in increased expression of GDF15 mRNA CTD PMID:15205334 more ... doxorubicin decreases response to substance ISO RGD:1344001 6480464 GDF15 protein results in decreased susceptibility to Doxorubicin CTD PMID:22615612 endosulfan multiple interactions ISO RGD:1344001 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of GDF15 mRNA CTD PMID:26159488 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of GDF15 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1344001 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDF15 mRNA CTD PMID:19167446 entinostat multiple interactions ISO RGD:1344001 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDF15 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1344001 6480464 entinostat results in increased expression of GDF15 mRNA CTD PMID:26272509 epoxiconazole decreases expression ISO RGD:735622 6480464 epoxiconazole results in decreased expression of GDF15 mRNA CTD PMID:35436446 erlotinib hydrochloride multiple interactions ISO RGD:1344001 6480464 [Gemcitabine co-treated with Erlotinib Hydrochloride] affects the expression of GDF15 protein CTD PMID:24979617 ethanol increases expression ISO RGD:1344001 6480464 Ethanol results in increased expression of GDF15 mRNA CTD PMID:28986285 ethyl methanesulfonate increases expression ISO RGD:1344001 6480464 Ethyl Methanesulfonate results in increased expression of GDF15 mRNA CTD PMID:23649840 , PMID:24211769 etoposide multiple interactions ISO RGD:1344001 6480464 Etoposide promotes the reaction [[TP53 protein binds to GDF15 promoter] which results in increased expression of GDF15 mRNA] CTD PMID:11895857 etoposide increases expression ISO RGD:1344001 6480464 [Etoposide results in increased expression of TP53 protein] which results in increased expression of GDF15 protein more ... CTD PMID:11895857 more ... fenamidone increases expression ISO RGD:735622 6480464 fenamidone results in increased expression of GDF15 mRNA CTD PMID:27029645 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of GDF15 mRNA CTD PMID:25596134 fenofibrate increases expression ISO RGD:1344001 6480464 Fenofibrate results in increased expression of GDF15 mRNA CTD PMID:25596134 fenpyroximate increases expression ISO RGD:1344001 6480464 fenpyroximate results in increased expression of GDF15 mRNA CTD PMID:33512557 flurbiprofen increases expression ISO RGD:1344001 6480464 Flurbiprofen results in increased expression of GDF15 protein CTD PMID:21097678 flurbiprofen multiple interactions ISO RGD:1344001 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Flurbiprofen results in increased expression of GDF15 protein] more ... CTD PMID:21097678 flutamide increases expression EXP 6480464 Flutamide results in increased expression of GDF15 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:1344001 6480464 Folic Acid affects the reaction [Cisplatin affects the expression of GDF15 mRNA] CTD PMID:16898872 folic acid decreases expression ISO RGD:735622 6480464 Folic Acid results in decreased expression of GDF15 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1344001 6480464 Formaldehyde results in increased expression of GDF15 mRNA CTD PMID:23649840 formaldehyde decreases expression ISO RGD:1344001 6480464 Formaldehyde results in decreased expression of GDF15 mRNA CTD PMID:28937961 furan increases expression ISO RGD:735622 6480464 furan results in increased expression of GDF15 mRNA CTD PMID:24183702 , PMID:24910943 furan decreases expression EXP 6480464 furan results in decreased expression of GDF15 mRNA CTD PMID:26194646 furan increases methylation EXP 6480464 furan results in increased methylation of GDF15 gene CTD PMID:22079235 furan multiple interactions ISO RGD:735622 6480464 [Bromodeoxyuridine co-treated with furan] results in increased expression of GDF15 mRNA CTD PMID:24910943 gedunin increases expression ISO RGD:1344001 6480464 gedunin results in increased expression of GDF15 mRNA CTD PMID:17010675 gemcitabine multiple interactions ISO RGD:1344001 6480464 [Gemcitabine co-treated with Erlotinib Hydrochloride] affects the expression of GDF15 protein CTD PMID:24979617 genistein increases expression ISO RGD:735622 6480464 Genistein results in increased expression of GDF15 mRNA CTD PMID:16169203 genistein increases expression ISO RGD:1344001 6480464 Genistein results in increased expression of GDF15 mRNA CTD PMID:22228119 , PMID:26865667 genistein decreases expression ISO RGD:1344001 6480464 Genistein results in decreased expression of GDF15 mRNA CTD PMID:20884965 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of GDF15 mRNA CTD PMID:22061828 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of GDF15 mRNA CTD PMID:33387578 gingerol multiple interactions ISO RGD:1344001 6480464 GSK3B protein affects the reaction [gingerol results in increased expression of GDF15 protein] more ... CTD PMID:18058799 gingerol increases expression ISO RGD:1344001 6480464 gingerol results in increased expression of GDF15 mRNA, gingerol results in increased expression of GDF15 protein CTD PMID:18058799 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GDF15 mRNA CTD PMID:33854195 graphene oxide decreases expression ISO RGD:735622 6480464 graphene oxide results in decreased expression of GDF15 mRNA CTD PMID:33227293 graphite affects expression EXP 6480464 Graphite affects the expression of GDF15 mRNA CTD PMID:29933104 hydrogen peroxide affects expression ISO RGD:1344001 6480464 Hydrogen Peroxide affects the expression of GDF15 mRNA CTD PMID:20044591 hydrogen peroxide decreases expression ISO RGD:735622 6480464 Hydrogen Peroxide results in decreased expression of GDF15 mRNA CTD PMID:35123994 hydrogen peroxide multiple interactions ISO RGD:1344001 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of GDF15 protein CTD PMID:18951874 hydrogen peroxide increases expression ISO RGD:1344001 6480464 Hydrogen Peroxide results in increased expression of GDF15 more ... CTD PMID:12414654 more ... hydroquinone increases expression ISO RGD:1344001 6480464 hydroquinone results in increased expression of GDF15 mRNA CTD PMID:23416264 , PMID:31256213 hydroxyurea increases expression ISO RGD:1344001 6480464 Hydroxyurea results in increased expression of GDF15 mRNA CTD PMID:24211769 ibuprofen increases expression ISO RGD:1344001 6480464 Ibuprofen results in increased expression of GDF15 mRNA, Ibuprofen results in increased expression of GDF15 protein CTD PMID:15555568 more ... ibuprofen multiple interactions ISO RGD:1344001 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Ibuprofen results in increased expression of GDF15 protein] more ... CTD PMID:21097678 ifosfamide increases expression ISO RGD:1344001 6480464 Ifosfamide results in increased expression of GDF15 mRNA CTD PMID:25596134 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GDF15 mRNA CTD PMID:33854195 imidazopyrazole increases expression ISO RGD:1344001 6480464 imidazopyrazole analog results in increased expression of GDF15 mRNA CTD PMID:30388846 indole-3-methanol increases expression ISO RGD:1344001 6480464 indole-3-carbinol results in increased expression of GDF15 CTD PMID:15670751 indole-3-methanol multiple interactions ISO RGD:1344001 6480464 [indole-3-carbinol co-treated with resveratrol] results in increased expression of GDF15 CTD PMID:15670751 indometacin increases expression ISO RGD:735622 6480464 Indomethacin results in increased expression of GDF15 mRNA CTD PMID:18076062 indometacin multiple interactions ISO RGD:1344001 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GDF15 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of GDF15 mRNA CTD PMID:28628672 indometacin decreases response to substance ISO RGD:1344001 6480464 GDF15 protein results in decreased susceptibility to Indomethacin CTD PMID:22615612 indometacin increases expression ISO RGD:1344001 6480464 Indomethacin results in increased expression of GDF15 mRNA, Indomethacin results in increased expression of GDF15 protein CTD PMID:15180942 more ... inulin multiple interactions ISO RGD:735622 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GDF15 mRNA CTD PMID:36331819 irinotecan increases expression ISO RGD:1344001 6480464 Irinotecan metabolite results in increased expression of GDF15 mRNA, Irinotecan results in increased expression of GDF15 mRNA CTD PMID:15956246 isotretinoin increases expression ISO RGD:1344001 6480464 Isotretinoin results in increased expression of GDF15 mRNA CTD PMID:15982314 ivermectin increases expression ISO RGD:735622 6480464 Ivermectin results in increased expression of GDF15 mRNA CTD PMID:28942281 ivermectin decreases expression ISO RGD:1344001 6480464 Ivermectin results in decreased expression of GDF15 protein CTD PMID:32959892 jaspamide multiple interactions ISO RGD:1344001 6480464 [SB 203580 co-treated with 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine] inhibits the reaction [jasplakinolide results in increased expression of GDF15 protein] CTD PMID:23996089 jaspamide increases expression ISO RGD:1344001 6480464 jasplakinolide results in increased expression of GDF15 mRNA, jasplakinolide results in increased expression of GDF15 protein CTD PMID:23996089 Lasiocarpine increases expression ISO RGD:1344001 6480464 lasiocarpine results in increased expression of GDF15 mRNA CTD PMID:32234424 , PMID:35690182 latrunculin B multiple interactions ISO RGD:1344001 6480464 [SB 203580 co-treated with 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine] inhibits the reaction [latrunculin B results in increased expression of GDF15 protein] CTD PMID:23996089 latrunculin B increases expression ISO RGD:1344001 6480464 latrunculin B results in increased expression of GDF15 mRNA, latrunculin B results in increased expression of GDF15 protein CTD PMID:23996089 lead diacetate multiple interactions ISO RGD:1344001 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GDF15 mRNA CTD PMID:12634122 leflunomide increases expression ISO RGD:1344001 6480464 leflunomide results in increased expression of GDF15 mRNA CTD PMID:28988120 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of GDF15 mRNA CTD PMID:35283115 lipopolysaccharide decreases expression ISO RGD:735622 6480464 Lipopolysaccharides results in decreased expression of GDF15 mRNA CTD PMID:27339419 lipopolysaccharide multiple interactions ISO RGD:1344001 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of GDF15 mRNA more ... CTD PMID:35811015 , PMID:35877022 lucanthone increases expression ISO RGD:1344001 6480464 Lucanthone results in increased expression of GDF15 mRNA CTD PMID:21148553 manganese atom increases expression ISO RGD:1344001 6480464 Manganese results in increased expression of GDF15 mRNA CTD PMID:17175027 manganese(0) increases expression ISO RGD:1344001 6480464 Manganese results in increased expression of GDF15 mRNA CTD PMID:17175027 manganese(II) chloride increases expression ISO RGD:1344001 6480464 manganese chloride results in increased expression of GDF15 mRNA CTD PMID:17175027 menadione affects expression ISO RGD:1344001 6480464 Vitamin K 3 affects the expression of GDF15 mRNA CTD PMID:20044591 menadione increases expression ISO RGD:1344001 6480464 Vitamin K 3 results in increased expression of GDF15 mRNA CTD PMID:12414654 mercury dibromide increases expression ISO RGD:1344001 6480464 mercuric bromide results in increased expression of GDF15 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1344001 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDF15 mRNA CTD PMID:27188386 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of GDF15 mRNA CTD PMID:16507785 metacetamol decreases expression ISO RGD:735622 6480464 3-hydroxyacetanilide results in decreased expression of GDF15 mRNA CTD PMID:18544908 metformin increases expression EXP 6480464 Metformin results in increased expression of GDF15 mRNA CTD PMID:25596134 methamphetamine increases expression ISO RGD:1344001 6480464 Methamphetamine results in increased expression of GDF15 mRNA CTD PMID:25290377 methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of GDF15 mRNA CTD PMID:19564919 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of GDF15 mRNA CTD PMID:19564919 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of GDF15 mRNA CTD PMID:15890375 , PMID:30467583 methyl methanesulfonate increases expression ISO RGD:1344001 6480464 Methyl Methanesulfonate results in increased expression of GDF15 mRNA CTD PMID:23649840 , PMID:24211769 methylarsonic acid multiple interactions ISO RGD:735622 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GDF15 mRNA CTD PMID:34876320 methylmercury chloride increases expression ISO RGD:1344001 6480464 methylmercuric chloride results in increased expression of GDF15 mRNA CTD PMID:26272509 , PMID:28001369 methylparaben increases expression ISO RGD:1344001 6480464 methylparaben results in increased expression of GDF15 mRNA CTD PMID:31745603 mitomycin C increases expression ISO RGD:1344001 6480464 Mitomycin results in increased expression of GDF15 mRNA CTD PMID:24211769 Mitotane increases expression ISO RGD:1344001 6480464 Mitotane results in increased expression of GDF15 mRNA CTD PMID:22966885 mitoxantrone increases expression ISO RGD:1344001 6480464 Mitoxantrone results in increased expression of GDF15 mRNA CTD PMID:26537877 , PMID:28940058 N-acetyl-L-cysteine multiple interactions ISO RGD:735622 6480464 Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of GDF15 mRNA] CTD PMID:35123994 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:735622 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GDF15 mRNA] CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:735622 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GDF15 mRNA CTD PMID:25566086 N-ethyl-N-nitrosourea increases expression ISO RGD:735622 6480464 Ethylnitrosourea results in increased expression of GDF15 mRNA CTD PMID:19100860 N-methyl-4-phenylpyridinium increases expression ISO RGD:1344001 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GDF15 mRNA CTD PMID:24810058 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:1344001 6480464 Methylnitronitrosoguanidine results in increased expression of GDF15 mRNA CTD PMID:12634122 , PMID:12773770 N-methylformamide increases expression ISO RGD:735622 6480464 methylformamide analog results in increased expression of GDF15 mRNA, methylformamide results in increased expression of GDF15 mRNA CTD PMID:17040096 N-nitrosodiethylamine increases expression ISO RGD:1344001 6480464 Diethylnitrosamine results in increased expression of GDF15 mRNA CTD PMID:21527772 N-nitrosodiethylamine increases expression ISO RGD:735622 6480464 Diethylnitrosamine results in increased expression of GDF15 mRNA CTD PMID:19100860 , PMID:21607683 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of GDF15 mRNA CTD PMID:14600272 , PMID:15890375 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of GDF15 mRNA CTD PMID:19716841 N-Nitrosopyrrolidine increases expression ISO RGD:1344001 6480464 N-Nitrosopyrrolidine results in increased expression of GDF15 mRNA CTD PMID:32234424 , PMID:35690182 naphthalene increases expression ISO RGD:735622 6480464 naphthalene results in increased expression of GDF15 mRNA CTD PMID:18978301 naphthalene increases expression EXP 6480464 naphthalene analog results in increased expression of GDF15 mRNA CTD PMID:24976557 nickel dichloride increases expression ISO RGD:1344001 6480464 nickel chloride results in increased expression of GDF15 mRNA CTD PMID:17312168 nickel sulfate increases expression ISO RGD:1344001 6480464 nickel sulfate results in increased expression of GDF15 mRNA CTD PMID:18651567 NS-398 increases expression ISO RGD:1344001 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of GDF15 protein CTD PMID:15180942 Nutlin-3 increases expression ISO RGD:1344001 6480464 nutlin 3 results in increased expression of GDF15 mRNA CTD PMID:16439677 O-methyleugenol increases expression ISO RGD:1344001 6480464 methyleugenol results in increased expression of GDF15 mRNA CTD PMID:32234424 , PMID:35690182 Octicizer multiple interactions ISO RGD:735622 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of GDF15 mRNA CTD PMID:33367866 octreotide multiple interactions ISO RGD:1344001 6480464 [Celecoxib co-treated with Octreotide] results in increased expression of GDF15 mRNA CTD PMID:17959037 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of GDF15 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GDF15 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:735622 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of GDF15 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO RGD:1344001 6480464 p-Chloromercuribenzoic Acid results in increased expression of GDF15 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1344001 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDF15 mRNA CTD PMID:27188386 paracetamol multiple interactions ISO RGD:735622 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GDF15 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GDF15 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GDF15 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1344001 6480464 Acetaminophen results in increased expression of GDF15 mRNA CTD PMID:29067470 paracetamol affects expression ISO RGD:735622 6480464 Acetaminophen affects the expression of GDF15 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:735622 6480464 Acetaminophen results in increased expression of GDF15 mRNA CTD PMID:18544908 , PMID:26056430 paraquat increases expression ISO RGD:1344001 6480464 Paraquat results in increased expression of GDF15 mRNA CTD PMID:20883675 more ... paraquat increases expression EXP 6480464 Paraquat results in increased expression of GDF15 mRNA CTD PMID:32680482 pentanal increases expression ISO RGD:1344001 6480464 pentanal results in increased expression of GDF15 mRNA CTD PMID:26079696 perfluorodecanoic acid decreases expression ISO RGD:1344001 6480464 perfluorodecanoic acid results in decreased expression of GDF15 protein CTD PMID:32916415 perfluorononanoic acid increases expression ISO RGD:1344001 6480464 perfluoro-n-nonanoic acid results in increased expression of GDF15 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1344001 6480464 perfluorooctane sulfonic acid results in increased expression of GDF15 mRNA CTD PMID:27153767 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:735622 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GDF15 mRNA more ... CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:1344001 6480464 perfluorooctanoic acid results in increased expression of GDF15 mRNA, perfluorooctanoic acid results in increased expression of GDF15 protein CTD PMID:26879310 , PMID:36326898 perfluoroundecanoic acid decreases expression ISO RGD:1344001 6480464 perfluoroundecanoic acid results in decreased expression of GDF15 protein CTD PMID:32916415 phenobarbital multiple interactions ISO RGD:735622 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of GDF15 mRNA], NR1I3 protein promotes the reaction [Phenobarbital results in increased expression of GDF15 mRNA] CTD PMID:19482888 , PMID:19850644 phenobarbital increases expression ISO RGD:735622 6480464 Phenobarbital results in increased expression of GDF15 mRNA CTD PMID:19482888 more ... phenylephrine affects expression ISO RGD:1344001 6480464 Phenylephrine affects the expression of GDF15 mRNA CTD PMID:19505289 phenylmercury acetate increases expression ISO RGD:1344001 6480464 Phenylmercuric Acetate results in increased expression of GDF15 mRNA CTD PMID:26272509 phloroglucinol increases expression ISO RGD:1344001 6480464 Phloroglucinol analog results in increased expression of GDF15 protein CTD PMID:23178381 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1344001 6480464 [Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GDF15 protein, [SB 203580 co-treated with 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GDF15 protein] CTD PMID:23996089 , PMID:30218697 phorbol 13-acetate 12-myristate increases expression ISO RGD:1344001 6480464 Tetradecanoylphorbol Acetate results in increased expression of GDF15 protein CTD PMID:23996089 phosgene affects expression ISO RGD:735622 6480464 Phosgene affects the expression of GDF15 mRNA CTD PMID:16300373 picoxystrobin increases expression ISO RGD:1344001 6480464 picoxystrobin results in increased expression of GDF15 mRNA CTD PMID:33512557 pinosylvin increases expression ISO RGD:1344001 6480464 pinosylvin results in increased expression of GDF15 mRNA, pinosylvin results in increased expression of GDF15 protein CTD PMID:23333577 pioglitazone multiple interactions ISO RGD:735622 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of GDF15 mRNA CTD PMID:27935865 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of GDF15 mRNA CTD PMID:15890375 pirinixic acid multiple interactions ISO RGD:735622 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GDF15 mRNA, PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GDF15 mRNA] CTD PMID:19710929 , PMID:19850644 pirinixic acid increases expression ISO RGD:735622 6480464 pirinixic acid results in increased expression of GDF15 mRNA CTD PMID:18445702 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of GDF15 mRNA CTD PMID:15890375 piroxicam multiple interactions ISO RGD:1344001 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of GDF15 mRNA] CTD PMID:21858171 piroxicam decreases expression ISO RGD:1344001 6480464 Piroxicam results in decreased expression of GDF15 mRNA CTD PMID:21858171 platycodin D increases expression ISO RGD:1344001 6480464 platycodin D results in increased expression of GDF15 protein CTD PMID:18804340 potassium dichromate increases expression ISO RGD:1344001 6480464 Potassium Dichromate results in increased expression of GDF15 mRNA CTD PMID:18332044 progesterone increases expression ISO RGD:1344001 6480464 Progesterone results in increased expression of GDF15 mRNA CTD PMID:18037150 progesterone decreases expression ISO RGD:735622 6480464 Progesterone results in decreased expression of GDF15 mRNA CTD PMID:22238285 progesterone increases expression EXP 6480464 Progesterone results in increased expression of GDF15 mRNA CTD PMID:20726854 progesterone multiple interactions ISO RGD:1344001 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of GDF15 mRNA CTD PMID:20660070 propanal increases expression ISO RGD:1344001 6480464 propionaldehyde results in increased expression of GDF15 mRNA CTD PMID:26079696 prostaglandin J2 increases expression ISO RGD:1344001 6480464 9-deoxy-delta-9-prostaglandin D2 results in increased expression of GDF15 mRNA, 9-deoxy-delta-9-prostaglandin D2 results in increased expression of GDF15 protein CTD PMID:14662774 prostaglandin J2 multiple interactions ISO RGD:1344001 6480464 [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [9-deoxy-delta-9-prostaglandin D2 results in increased expression of GDF15 protein] CTD PMID:14662774 pterostilbene increases expression ISO RGD:1344001 6480464 pterostilbene results in increased expression of GDF15 mRNA CTD PMID:22450950 pyrimidifen increases expression ISO RGD:1344001 6480464 pyrimidifen results in increased expression of GDF15 mRNA CTD PMID:33512557 quercetin decreases expression ISO RGD:1344001 6480464 Quercetin results in decreased expression of GDF15 mRNA CTD PMID:15309432 quercetin increases expression ISO RGD:1344001 6480464 Quercetin results in increased expression of GDF15 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1344001 6480464 [indole-3-carbinol co-treated with resveratrol] results in increased expression of GDF15 more ... CTD PMID:11895857 more ... resveratrol increases expression ISO RGD:1344001 6480464 [Resveratrol results in increased expression of TP53 protein] which results in increased expression of GDF15 protein more ... CTD PMID:11895857 , PMID:17257620 Ro 31-8220 multiple interactions ISO RGD:1344001 6480464 Ro 31-8220 inhibits the reaction [gingerol results in increased expression of GDF15 protein] CTD PMID:18058799 rotenone increases expression EXP 6480464 Rotenone results in increased expression of GDF15 mRNA CTD PMID:27900601 rotenone increases expression ISO RGD:1344001 6480464 Rotenone results in increased expression of GDF15 mRNA CTD PMID:29955902 , PMID:33512557 rottlerin increases expression ISO RGD:1344001 6480464 rottlerin results in increased expression of GDF15 mRNA, rottlerin results in increased expression of GDF15 protein CTD PMID:22410117 rottlerin multiple interactions ISO RGD:1344001 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [rottlerin results in increased expression of GDF15 protein], SB 203580 inhibits the reaction [rottlerin results in increased expression of GDF15 protein] CTD PMID:22410117 rottlerin affects response to substance ISO RGD:1344001 6480464 GDF15 affects the susceptibility to rottlerin CTD PMID:22410117 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1344001 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of GDF15 mRNA CTD PMID:36576512 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1344001 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GDF15 mRNA CTD PMID:35811015 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression ISO RGD:735622 6480464 Buthionine Sulfoximine results in increased expression of GDF15 mRNA CTD PMID:35123994 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:735622 6480464 Acetylcysteine inhibits the reaction [Buthionine Sulfoximine results in increased expression of GDF15 mRNA] CTD PMID:35123994 SB 203580 multiple interactions ISO RGD:1344001 6480464 [SB 203580 co-treated with 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine] inhibits the reaction [jasplakinolide results in increased expression of GDF15 protein] more ... CTD PMID:22410117 more ... SB 431542 multiple interactions ISO RGD:1344001 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of GDF15 mRNA CTD PMID:19564919 Securinine increases expression ISO RGD:1344001 6480464 securinine results in increased expression of GDF15 mRNA CTD PMID:32662633 serpentine asbestos increases expression ISO RGD:1344001 6480464 Asbestos, Serpentine results in increased expression of GDF15 mRNA CTD PMID:24160326 silibinin increases expression ISO RGD:1344001 6480464 Silybin results in increased expression of GDF15 mRNA, Silybin results in increased expression of GDF15 protein CTD PMID:24440808 silibinin multiple interactions ISO RGD:1344001 6480464 EGR1 mutant form inhibits the reaction [Silybin results in increased expression of GDF15 protein] more ... CTD PMID:24440808 silicon dioxide increases expression ISO RGD:1344001 6480464 Silicon Dioxide analog results in increased expression of GDF15 mRNA CTD PMID:23806026 silicon dioxide increases expression ISO RGD:735622 6480464 Silicon Dioxide results in increased expression of GDF15 mRNA CTD PMID:19073995 more ... silver atom increases expression ISO RGD:735622 6480464 Silver results in increased expression of GDF15 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:735622 6480464 Silver results in increased expression of GDF15 mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO RGD:735622 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GDF15 mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RGD:1344001 6480464 sodium arsenite results in decreased expression of GDF15 mRNA CTD PMID:12634122 , PMID:34032870 sodium arsenite multiple interactions ISO RGD:735622 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GDF15 mRNA CTD PMID:34876320 sodium arsenite increases expression ISO RGD:735622 6480464 sodium arsenite results in increased expression of GDF15 mRNA CTD PMID:16014739 sodium arsenite increases expression ISO RGD:1344001 6480464 sodium arsenite results in increased expression of GDF15 mRNA, sodium arsenite results in increased expression of GDF15 protein CTD PMID:23876855 more ... sodium arsenite multiple interactions ISO RGD:1344001 6480464 [sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of GDF15 promoter, [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GDF15 mRNA CTD PMID:12634122 , PMID:18448484 sulindac increases expression ISO RGD:1344001 6480464 Sulindac results in increased expression of GDF15 mRNA, Sulindac results in increased expression of GDF15 protein CTD PMID:11906190 , PMID:15180942 sulindac increases expression ISO RGD:735622 6480464 Sulindac results in increased expression of GDF15 protein CTD PMID:11984525 sulindac sulfide multiple interactions ISO RGD:1344001 6480464 EGR1 protein promotes the reaction [sulindac sulfide results in increased expression of GDF15 mRNA] CTD PMID:15509713 sulindac sulfide increases expression ISO RGD:735622 6480464 sulindac sulfide results in increased expression of GDF15 mRNA CTD PMID:18076062 sulindac sulfide increases expression ISO RGD:1344001 6480464 sulindac sulfide results in increased expression of GDF15 mRNA, sulindac sulfide results in increased expression of GDF15 protein CTD PMID:11895857 more ... sunitinib increases expression ISO RGD:1344001 6480464 Sunitinib results in increased expression of GDF15 mRNA CTD PMID:31533062 T-2 toxin increases expression ISO RGD:1344001 6480464 T-2 Toxin results in increased expression of GDF15 mRNA CTD PMID:34581912 tamoxifen increases expression ISO RGD:735622 6480464 Tamoxifen results in increased expression of GDF15 mRNA CTD PMID:25123088 tamoxifen decreases response to substance ISO RGD:1344001 6480464 GDF15 protein results in decreased susceptibility to Tamoxifen CTD PMID:22615612 tamoxifen affects expression ISO RGD:735622 6480464 Tamoxifen affects the expression of GDF15 mRNA CTD PMID:20937368 tebufenpyrad increases expression ISO RGD:1344001 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of GDF15 mRNA CTD PMID:33512557 temozolomide increases expression ISO RGD:1344001 6480464 Temozolomide results in increased expression of GDF15 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO RGD:1344001 6480464 tert-Butylhydroperoxide results in increased expression of GDF15 mRNA CTD PMID:12414654 tetrachloromethane increases expression ISO RGD:735622 6480464 Carbon Tetrachloride results in increased expression of GDF15 mRNA CTD PMID:31919559 tetraphene multiple interactions ISO RGD:735622 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GDF15 mRNA CTD PMID:27858113 thapsigargin increases expression ISO RGD:1344001 6480464 Thapsigargin results in increased expression of GDF15 mRNA CTD PMID:22378314 theophylline multiple interactions ISO RGD:1344001 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of GDF15 protein CTD PMID:18951874 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GDF15 mRNA CTD PMID:33854195 thifluzamide increases expression ISO RGD:1344001 6480464 thifluzamide results in increased expression of GDF15 mRNA CTD PMID:33512557 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GDF15 mRNA CTD PMID:23411599 , PMID:34492290 thiostrepton increases expression ISO RGD:1344001 6480464 Thiostrepton results in increased expression of GDF15 mRNA CTD PMID:22321511 titanium dioxide increases expression ISO RGD:735622 6480464 titanium dioxide results in increased expression of GDF15 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:1344001 6480464 [Vitallium analog binds to titanium dioxide] which results in increased expression of GDF15 mRNA CTD PMID:23825117 topotecan increases expression EXP 6480464 Topotecan results in increased expression of GDF15 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GDF15 mRNA CTD PMID:25729387 trans-pinosylvin increases expression ISO RGD:1344001 6480464 pinosylvin results in increased expression of GDF15 mRNA, pinosylvin results in increased expression of GDF15 protein CTD PMID:23333577 tributyl phosphate multiple interactions ISO RGD:735622 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of GDF15 mRNA CTD PMID:33367866 trichloroethene increases expression ISO RGD:735622 6480464 Trichloroethylene results in increased expression of GDF15 mRNA CTD PMID:25549359 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of GDF15 mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO RGD:1344001 6480464 [trichostatin A results in increased expression of GDF15 protein] which results in increased cleavage of PARP1 protein more ... CTD PMID:18801729 trichostatin A increases expression ISO RGD:1344001 6480464 trichostatin A results in increased expression of GDF15 mRNA CTD PMID:24935251 triphenyl phosphate multiple interactions ISO RGD:735622 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of GDF15 mRNA CTD PMID:33367866 triptonide increases expression ISO RGD:735622 6480464 triptonide results in increased expression of GDF15 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate multiple interactions ISO RGD:735622 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of GDF15 mRNA CTD PMID:33367866 tris(2-chloroethyl) phosphate multiple interactions ISO RGD:735622 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1, 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of GDF15 mRNA CTD PMID:33367866 troglitazone multiple interactions ISO RGD:1344001 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone results in increased expression of GDF15 protein] more ... CTD PMID:14662774 troglitazone increases expression ISO RGD:1344001 6480464 troglitazone results in increased expression of GDF15 mRNA, troglitazone results in increased expression of GDF15 protein CTD PMID:14662774 more ... Tungsten carbide multiple interactions ISO RGD:1344001 6480464 [tungsten carbide binds to Cobalt] which affects the expression of GDF15 mRNA CTD PMID:20105288 tunicamycin increases expression ISO RGD:1344001 6480464 Tunicamycin results in increased expression of GDF15 mRNA CTD PMID:22378314 urethane increases expression ISO RGD:1344001 6480464 Urethane results in increased expression of GDF15 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1344001 6480464 Valproic Acid affects the expression of GDF15 mRNA CTD PMID:25979313 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of GDF15 mRNA CTD PMID:35594946 valproic acid increases expression ISO RGD:1344001 6480464 Valproic Acid results in increased expression of GDF15 mRNA CTD PMID:23179753 more ... vincristine increases expression ISO RGD:1344001 6480464 Vincristine results in increased expression of GDF15 mRNA CTD PMID:23649840 wortmannin increases expression ISO RGD:1344001 6480464 wortmannin results in increased expression of GDF15 protein CTD PMID:23178381 zinc atom multiple interactions ISO RGD:1344001 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of GDF15 mRNA CTD PMID:18593933 zinc atom multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in increased expression of GDF15 mRNA] CTD PMID:19111725 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of GDF15 mRNA CTD PMID:19111725 zinc oxide decreases expression EXP 6480464 Zinc Oxide results in decreased expression of GDF15 protein CTD PMID:33205376 zinc pyrithione increases expression ISO RGD:1344001 6480464 pyrithione zinc results in increased expression of GDF15 mRNA CTD PMID:21424779 zinc(0) multiple interactions ISO RGD:1344001 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of GDF15 mRNA CTD PMID:18593933 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of GDF15 mRNA CTD PMID:19111725 zinc(0) multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in increased expression of GDF15 mRNA] CTD PMID:19111725 zoledronic acid decreases expression ISO RGD:1344001 6480464 zoledronic acid results in decreased expression of GDF15 mRNA CTD PMID:24714768 , PMID:25596134
